JPS58185553A - Alpha-protected oxyimino-beta-keto-gamma-halogenobutyric acid - Google Patents
Alpha-protected oxyimino-beta-keto-gamma-halogenobutyric acidInfo
- Publication number
- JPS58185553A JPS58185553A JP58012560A JP1256083A JPS58185553A JP S58185553 A JPS58185553 A JP S58185553A JP 58012560 A JP58012560 A JP 58012560A JP 1256083 A JP1256083 A JP 1256083A JP S58185553 A JPS58185553 A JP S58185553A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- protected
- compound
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、式
(式中、Xl−4ハロケンf、Y トJ)i−NR5(
R5は保護された水酸基)で表わされる基を示す。〕で
表わされる化合物、その基壇たはエステル、及びその製
造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a compound having the formula (wherein,
R5 represents a group represented by a protected hydroxyl group. ], its base or ester, and its production method.
本発明の化合物〔罵〕、その権またはエステルは、式
%式%
1武中、B12は低級アルコキシ基tたは保護されでい
てもよいアミノ基を示す。〕で表わされる化合物と反応
させ、要すれば保護基を除去することにより、式
〔一式中、′R13は水酸基または保護されていてもよ
いアミノ基を、他は前記と同、f表。〕で表わされる化
合物を製進する丸めの有用な合成中間体であって、得ら
れる化合物CXIV)は、たとえば式〔式中、R3は水
素またはメトキン1&を、R4は水素または求核性化合
物残基を示す。〕で表わされる化合物と反応させ、要す
れば保護基を除去して、広くダラム嚇性繭、鴎性−に対
し高い抗菌力をボす式
〔式中の記号は前記と同意義。〕で表わされる化合物な
どを#造するのに有用である。The compound of the present invention, its right or ester, has the formula % Formula % 1 where B12 represents a lower alkoxy group or an optionally protected amino group. By reacting with a compound represented by the formula [In the formula, R13 is a hydroxyl group or an optionally protected amino group, the others are the same as above, Table f. ], the resulting compound CXIV) is a useful synthetic intermediate for the preparation of compounds of the formula Indicates the group. [Symbols in the formula have the same meanings as above. It is useful for producing compounds represented by the following.
化合物〔1〕において、XとYは一緒になって武−NR
5で表わされる基を示し、R5は保−された水酸J&を
示す。このような水酸基の保護基としては本発14iI
IKおける各反応を阻害しない限りいかなるものでもよ
く通常メチμ、エチルのような低級アルキル基、フェニ
ル、チエ二μのようなアリール基、アセチル、ベンゾイ
ルのようなアy)v基が用いられる。化合物〔罵〕中、
XFi樵素、臭素。In compound [1], X and Y together form -NR
5, and R5 represents a preserved hydroxyl J&. As a protecting group for such a hydroxyl group, the present invention 14iI
Any group may be used as long as it does not inhibit each reaction in IK, and usually lower alkyl groups such as methyμ and ethyl, aryl groups such as phenyl and thiene, and y)v groups such as acetyl and benzoyl are used. During the compound [expletive]
XFi woodcutter, bromine.
ヨウ素、フッ章などのハロゲンを示す。ti、力〜ボキ
Vル基は保−されていてもよい。このような保−基とし
ては、酸性条件、アルカリ性条件。Indicates halogens such as iodine and fluoride. The ti, and the groups may be retained. Such holding groups include acidic conditions and alkaline conditions.
遁元条件等の緩和な条件で除去しうるものなら何でもよ
く、たとえば一般にペプチド合成においてカルボキシル
基の保−基として用いられるものから選択され、たとえ
ばメチル、エチル、プロピル。Any group may be used as long as it can be removed under mild conditions such as release conditions, and is selected from those generally used as carboxyl group holding groups in peptide synthesis, such as methyl, ethyl, and propyl.
イソプロピル、ブチル、第2ブチμ、イソグチル。Isopropyl, butyl, sec-butyl, isobutyl.
第3グチルなどのアルキル基、β−メチμスルホニルエ
チル、トリクロルエチル、ジフェニルメチルなどの直涙
アルキル基、フェニル、トリルナトのアリー/l’基、
l)−第3ブチ〜フエニル、p−ニトロフエニlL/
ナトのWt俟アリール基、ベンジル。Alkyl groups such as tertiary glutyl, direct alkyl groups such as β-methyμsulfonyl ethyl, trichloroethyl, diphenylmethyl, ary/l' groups of phenyl, tolylunato,
l)-tertiary buty-phenyl, p-nitrophenyl/
Nat's Wt aryl group, benzyl.
フェネチル、トルベンジルなどの7フルキA’基。7-fulky A' group such as phenethyl and tolbendyl.
p−メトキンベンジル、p−ニトロベンジ/L/ナトの
置換アフ々キル晟などが用いられる。この化合物〔虐〕
は保^され九オキシイミノ基に関して坤纜的に5yn−
およびanti−の絢異性体が存在し、両者とも同様に
有用な合成中間体として用いられる。p-methquinbenzyl, p-nitrobenzyl/L/nato substituted afkyl, etc. are used. This compound
is preserved and is strictly 5yn- with respect to the 9oximino group.
and anti-isomers exist, both of which are equally useful synthetic intermediates.
化合物〔−M〕は、対応するα位に保護されたオキシイ
ミノ基を有するβ−ケト酪#lIAを常法に便ってハロ
ゲン化することによって得られる。Compound [-M] can be obtained by halogenating β-ketobutyric #lIA having a corresponding oximino group protected at the α-position using a conventional method.
5fi!施例1
α−エトキンイミノ−β−ケト酪酸エチルエステル18
.7fをクロロホルム100s/に溶解し、水冷下に臭
素15.9fをクロロホルム20s/に溶解した故を徐
々に滴トする。30分間攪拌したのち、寥温にもどして
さらに1.5時間攪拌する。反応混合物を水洗し、廣酸
水素ナトリウム水浴液にて沈降したのち、さらに水洗し
硫酸マグネシウムで乾燥する。溶媒留去後エタノ−7’
250srを加え、チオ尿意15.2fを加えて2時間
還流する。5fi! Example 1 α-ethquinimino-β-ketobutyric acid ethyl ester 18
.. 7f was dissolved in 100s/chloroform, and a solution of 15.9f bromine dissolved in 20s/chloroform was gradually added dropwise while cooling with water. After stirring for 30 minutes, the mixture was returned to the original temperature and stirred for an additional 1.5 hours. The reaction mixture was washed with water, precipitated in a sodium hydrogen hydroxide bath, further washed with water, and dried over magnesium sulfate. After solvent distillation, ethanol-7'
Add 250sr, add 15.2f of thiourine, and reflux for 2 hours.
冷却し九のち溶媒を減圧留去し、残留物に水250dを
加えると固体が析出する。これを′f3取し、水洗した
のち乾燥するとα−エトキンイミノ−2−アミノチアゾ
−〜−4−イfi7#酸エチルエステμ臭化水嵩酸樵1
7.9fが得られる。収率55襲。After cooling, the solvent was distilled off under reduced pressure and 250 d of water was added to the residue to precipitate a solid. This was taken out, washed with water, and then dried.
7.9f is obtained. Yield: 55%.
元素分析値 C,Ii、4N303SBr針算値: C
,33,34; H4,35+ N 12.9&wS値
: c 32.52+ II 3.98; x 12.
92本品の核磁気共鳴スペクトル(100MHz、d6
−1)M2O中)は1.30および1.32ppmK2
橋類のエチル基メチル水素の三重線、4.28および4
、37 ppm+に2櫨艙のエチル基メチレン水嵩の四
重纏、7.63ppmにチアゾール5位水素の単線、9
、12 pprnにアミノ基水素の巾広い単線共鳴線を
ボす。Elemental analysis value C, Ii, 4N303SBr needle value: C
, 33, 34; H4, 35+ N 12.9&wS value: c 32.52+ II 3.98; x 12.
92 Nuclear magnetic resonance spectrum of this product (100MHz, d6
-1) in M2O) is 1.30 and 1.32 ppm K2
Bridges ethyl group methyl hydrogen triplet, 4.28 and 4
, a quadruple coat of ethyl group methylene water volume of 2 h at 37 ppm+, a single line of hydrogen at the 5-position of thiazole at 7.63 ppm, 9
, 12 pprn shows a wide single resonance line of amino group hydrogen.
東施例2
(1)α−メトキシイミノ−ρ−ケト醋酸エチル27.
31をクロロホルム120dに溶かし、これに氷〜ト臭
素25.3fをクロロホルム30mK浴かした猷を30
分間で滴丁する。その後室温で1時間rJl井し反応さ
せる。反応物を希**水嵩ナトリウム水溶猷、水で洗浄
した後有機層を乾燥する。浴剤を留去して粗製のα−メ
トキメイミノ−β−ケト−γ−10ム醋酸エチルを油状
物として得る。East Example 2 (1) Ethyl α-methoxyimino-ρ-keto acetate 27.
31 was dissolved in 120 d of chloroform, and 25.3 f of ice to bromine was bathed in 30 mK of chloroform.
Drop in minutes. Thereafter, the mixture was allowed to react at room temperature for 1 hour. The reaction product was washed with dilute sodium chloride solution and water, and the organic layer was dried. The bath agent is distilled off to obtain crude ethyl acetate as an oil.
(2)氷晶全量をエタノ−A/250mK浴かし、これ
にチオ尿素249を加えてavf間加熱加熱還流る。(2) The entire amount of ice crystals is placed in an ethanol-A/250 mK bath, thiourea 249 is added thereto, and the mixture is heated to reflux during avf.
冷後析出物を1取しエタノールで洗浄する。得られ九結
晶状物賞を酢酸エチルコテトラヒドロフラン(1:1)
混合物300m/に懸濁し10%炭酸水素ナトリウム水
溶液を200s/加えてよくふシf#4′機鳩を分取す
る。乾燥後溶剤を留去して得られた結晶をエーテルで洗
浄しα−メトキシイミノ−α−(2−アミノチアゾール
−4−イA/)glillエチルを得る。16.86F
、融点112〜113℃。After cooling, take one precipitate and wash with ethanol. The nine crystals obtained were ethylcotetrahydrofuran acetate (1:1)
Suspend the mixture in 300 m/ml, add 10% aqueous sodium bicarbonate solution for 200 s/ml, and separate the F#4' pigeons. After drying, the solvent was distilled off and the resulting crystals were washed with ether to obtain α-methoxyimino-α-(2-aminothiazol-4-yA/)grill ethyl. 16.86F
, melting point 112-113°C.
元素分析値 C8Hよ、N303S
*tJ:値: C41,91i H4,84寮I8値:
c 41,20; H4,70核磁気共鳴スペクト/
L/(60MHz、CDCl3中)は4、04 ppm
にメトキシ水素の単線、7.44ppmにチアゾール1
15位水素の単線共鳴線を示す。Elemental analysis value C8H, N303S *tJ: value: C41,91i H4,84 dormitory I8 value:
c 41,20; H4,70 nuclear magnetic resonance spectrum/
L/(60MHz, in CDCl3) is 4.04 ppm
single line of methoxy hydrogen, thiazole 1 at 7.44 ppm
A single resonance line of hydrogen at position 15 is shown.
Claims (1)
−NJ?5(1?5 は保護された水酸基を示す)で表
わされる基を示す〕で表わされる化合物、その墳または
エステ〜。 (2ン式 し式中、Yと2は一緒になって武=NR5(R5は体層
された水酸基を示す)で表わされる基を示す〕で表わさ
れる化合物、その墳またはエステA/′にハロゲン化す
ることを特徴とする式 1式中、XFiハロゲン原子を、Y、ZV1前記と同t
IIIIを示す〕で表わされる化合物、その塩を九はエ
ステルの製造法。[Claims] (In formula 11C, X represents a halogen atom, and Y and 2 together represent a group represented by the formula -NJ?5 (1?5 represents a protected hydroxyl group) ] Compounds, their mounds or esthetics ~ (In the formula, Y and 2 together represent a group represented by MU = NR5 (R5 represents a layered hydroxyl group)) In the formula 1, the XFi halogen atom is replaced by Y, ZV1, the same t as above.
9 is a method for producing an ester of a compound represented by III] and its salt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB24611/75A GB1536281A (en) | 1975-06-09 | 1975-06-09 | Cephem compounds |
GB24611/75 | 1975-06-09 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56087403A Division JPS5858353B2 (en) | 1975-06-09 | 1981-06-05 | Cefem or penam compound and its production method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58185553A true JPS58185553A (en) | 1983-10-29 |
JPS6155905B2 JPS6155905B2 (en) | 1986-11-29 |
Family
ID=10214399
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51067524A Expired JPS5822039B2 (en) | 1975-06-09 | 1976-06-08 | Thiazole compound and its manufacturing method |
JP56087403A Expired JPS5858353B2 (en) | 1975-06-09 | 1981-06-05 | Cefem or penam compound and its production method |
JP58012560A Granted JPS58185553A (en) | 1975-06-09 | 1983-01-27 | Alpha-protected oxyimino-beta-keto-gamma-halogenobutyric acid |
JP58178160A Pending JPS5989686A (en) | 1975-06-09 | 1983-09-28 | Cephem or penam compound |
JP60232072A Granted JPS61143388A (en) | 1975-06-09 | 1985-10-16 | Cephem compound |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51067524A Expired JPS5822039B2 (en) | 1975-06-09 | 1976-06-08 | Thiazole compound and its manufacturing method |
JP56087403A Expired JPS5858353B2 (en) | 1975-06-09 | 1981-06-05 | Cefem or penam compound and its production method |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58178160A Pending JPS5989686A (en) | 1975-06-09 | 1983-09-28 | Cephem or penam compound |
JP60232072A Granted JPS61143388A (en) | 1975-06-09 | 1985-10-16 | Cephem compound |
Country Status (7)
Country | Link |
---|---|
JP (5) | JPS5822039B2 (en) |
AT (2) | AT344894B (en) |
GB (1) | GB1536281A (en) |
HK (1) | HK2282A (en) |
HU (1) | HU172304B (en) |
MY (1) | MY8200219A (en) |
SE (1) | SE444809B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK154939C (en) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF |
GB1536281A (en) * | 1975-06-09 | 1978-12-20 | Takeda Chemical Industries Ltd | Cephem compounds |
FR2346014A1 (en) * | 1976-01-23 | 1977-10-28 | Roussel Uclaf | Amino-thiazolyl-hydroxyimino-acetamido-cephalosporanic acids - with antibacterial activity |
SE440655B (en) * | 1976-01-23 | 1985-08-12 | Roussel Uclaf | SET TO MAKE NEW OXIME DERIVATIVES OF 7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID |
GB1576625A (en) * | 1976-04-12 | 1980-10-08 | Fujisawa Pharmaceutical Co | Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof |
FI771866A (en) * | 1976-06-28 | 1977-12-29 | Fujisawa Pharmaceutical Co | |
PH17188A (en) * | 1977-03-14 | 1984-06-14 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and their pharmaceutical compositions and method of use |
ZA781502B (en) * | 1977-03-14 | 1979-09-26 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and processes for preparation thereof |
JPS5444695A (en) * | 1977-09-13 | 1979-04-09 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid and its salt and their preparation |
US4370326A (en) * | 1977-09-13 | 1983-01-25 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds and composition |
FR2410655A1 (en) * | 1977-12-05 | 1979-06-29 | Roussel Uclaf | NEW OXIMES DERIVED FROM 3-SUBSTITUTE 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS |
DE2758001A1 (en) * | 1977-12-24 | 1979-07-12 | Hoechst Ag | CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
FR2387235A1 (en) * | 1978-01-23 | 1978-11-10 | Fujisawa Pharmaceutical Co | PROCESS FOR THE PREPARATION OF COMPOUNDS OF 3,7-DISUBSTITUE-3-CEPHEM-4-CARBOXYLIC ACID AND NEW PRODUCTS THUS OBTAINED, HAVING A STRONG ANTIBACTERIAL ACTIVITY |
JPS54106495A (en) * | 1978-02-09 | 1979-08-21 | Dai Ichi Seiyaku Co Ltd | Cephem derivative |
JPS54128594A (en) * | 1978-03-27 | 1979-10-05 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid derivative |
FR2432521A1 (en) * | 1978-03-31 | 1980-02-29 | Roussel Uclaf | NOVEL O-SUBSTITUTED OXIMES DERIVED FROM 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS |
DE2818263A1 (en) * | 1978-04-26 | 1979-11-08 | Bayer Ag | BETA LACTAMANTIBIOTICS |
US4703046A (en) * | 1978-09-08 | 1987-10-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds and processes for preparation thereof |
BE878637A (en) * | 1978-09-11 | 1980-03-06 | Fujisawa Pharmaceutical Co | PROCESS FOR THE PREPARATION OF 3,7-DISUBSTITUTED 3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, NOVEL PRODUCTS THUS OBTAINED AND THEIR USE FOR THEIR ANTIMICROBIAL ACTIVITIES |
JPS5543089A (en) * | 1978-09-12 | 1980-03-26 | Fujisawa Pharmaceut Co Ltd | Preparation of 3-cephem compound |
JPS5594354A (en) * | 1979-01-12 | 1980-07-17 | Fujisawa Pharmaceut Co Ltd | Syn-isomer of 2-substituted imino-3-oxo-4-halobutyric acid, its salt, and their preparation |
US4409215A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
JPS56125392A (en) * | 1980-03-06 | 1981-10-01 | Fujisawa Pharmaceut Co Ltd | Cepham and cephem compound and preparation thereof |
JPS57154175A (en) * | 1981-03-16 | 1982-09-22 | Mitsui Toatsu Chem Inc | 2-thiazoleamine derivative, its preparation, and drug composition comprising it |
US4457929A (en) * | 1982-03-29 | 1984-07-03 | Bristol-Myers Company | 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives |
DE3374410D1 (en) | 1982-06-28 | 1987-12-17 | Bristol Myers Co | Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives |
IL69246A (en) * | 1982-08-07 | 1986-07-31 | Tanabe Seiyaku Co | 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
JPS6150973A (en) * | 1983-11-16 | 1986-03-13 | Fujisawa Pharmaceut Co Ltd | Substituted iminoacetic acid derivative and salt and preparation thereof |
IT1180207B (en) * | 1984-07-30 | 1987-09-23 | Istituto Biochimico Italiano | PROCEDURE FOR THE PREPARATION, WITH HIGH YIELD AND PURITY, OF BETA-LACTAMIC ANTIBIOTICS |
JPS60155167A (en) * | 1984-07-31 | 1985-08-15 | Fujisawa Pharmaceut Co Ltd | Substituted iminoacetic acid derivative and its salt |
JPS61121746U (en) * | 1985-01-16 | 1986-07-31 | ||
EP0210815A3 (en) * | 1985-07-25 | 1988-04-20 | Beecham Group Plc | 6-beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use |
GB8519606D0 (en) * | 1985-08-05 | 1985-09-11 | Fujisawa Pharmaceutical Co | 3 7-d substituted-3-cephem compounds |
EP0373216A4 (en) * | 1987-02-02 | 1992-08-12 | Teijin Limited | Cephalosporin compounds or their salts, process for their preparation, and parmaceutical compositions |
EP0347459A4 (en) * | 1987-02-03 | 1990-04-10 | Teijin Ltd | Cephalosporin compounds or their salts, process for their preparation, and pharmaceutical compositions. |
JPH02281051A (en) * | 1989-04-21 | 1990-11-16 | Toyo Tire & Rubber Co Ltd | Tread rubber composition for tire |
JPH09110877A (en) | 1995-10-17 | 1997-04-28 | Katayama Seiyakushiyo:Kk | Cephem compound, its production and antibacterial agent containing the compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1536281A (en) * | 1975-06-09 | 1978-12-20 | Takeda Chemical Industries Ltd | Cephem compounds |
-
1975
- 1975-06-09 GB GB24611/75A patent/GB1536281A/en not_active Expired
- 1975-12-17 HU HU75TA00001381A patent/HU172304B/en unknown
- 1975-12-19 AT AT967775A patent/AT344894B/en not_active IP Right Cessation
-
1976
- 1976-06-08 JP JP51067524A patent/JPS5822039B2/en not_active Expired
-
1977
- 1977-07-18 AT AT517177A patent/AT347587B/en not_active IP Right Cessation
- 1977-11-23 SE SE7713233A patent/SE444809B/en not_active IP Right Cessation
-
1981
- 1981-06-05 JP JP56087403A patent/JPS5858353B2/en not_active Expired
-
1982
- 1982-01-14 HK HK22/82A patent/HK2282A/en unknown
- 1982-12-30 MY MY219/82A patent/MY8200219A/en unknown
-
1983
- 1983-01-27 JP JP58012560A patent/JPS58185553A/en active Granted
- 1983-09-28 JP JP58178160A patent/JPS5989686A/en active Pending
-
1985
- 1985-10-16 JP JP60232072A patent/JPS61143388A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
AT347587B (en) | 1979-01-10 |
GB1536281A (en) | 1978-12-20 |
HU172304B (en) | 1978-07-28 |
JPS5858353B2 (en) | 1983-12-24 |
JPS61143388A (en) | 1986-07-01 |
SE7713233L (en) | 1977-11-23 |
JPS5756485A (en) | 1982-04-05 |
HK2282A (en) | 1982-01-22 |
JPS6155905B2 (en) | 1986-11-29 |
JPS5989686A (en) | 1984-05-23 |
JPS51149296A (en) | 1976-12-22 |
JPS5822039B2 (en) | 1983-05-06 |
AT344894B (en) | 1978-08-10 |
ATA967775A (en) | 1977-12-15 |
MY8200219A (en) | 1982-12-31 |
JPH0346474B2 (en) | 1991-07-16 |
ATA517177A (en) | 1978-05-15 |
SE444809B (en) | 1986-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS58185553A (en) | Alpha-protected oxyimino-beta-keto-gamma-halogenobutyric acid | |
CA1128957A (en) | .alpha.-PROTECTED OXYIMINO-.beta.-OXO-.gamma.-HALOGENOBUTYRIC ACID DERIVATIVES | |
JP2009524691A5 (en) | ||
JP2020521766A5 (en) | ||
JPH0242830B2 (en) | ||
JPS60105670A (en) | Novel oxime derivative of aminothiazolylacetic acid | |
JP2001506254A (en) | Method for producing thiazole derivative | |
JPH10509967A (en) | Process for producing 5-amino-2,4,6-triiodoisophthalic dichloride by chlorination of the corresponding acid in the presence of a tertiary amine salt or a quaternary ammonium salt | |
JPS5826342B2 (en) | Shinkipyrazolyl oxysaccharide composition | |
JPH06234754A (en) | Heterocyclic carboxylic acid derivative | |
US2971955A (en) | Cyclohexylcarbinol derivatives of piperazine | |
FI60550C (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV BENZYLAMINER | |
JPS60246382A (en) | Alkyl 2-(2-acylamidothiazol-4-yl)-2-butenoates and manufacture | |
US2097137A (en) | Ethers of 2,4-dinitro-6-cyclohexyl-phenol | |
JPS62120350A (en) | Manufacture of glycol amides | |
JPS5851943B2 (en) | Ethynyl cyclopropane carbonate ester | |
KR880001540B1 (en) | Process for preparing cephalesporins | |
JPS58140086A (en) | 4-(trans-5-alkyl-1, 3-dioxa-2-yl)benzoic acid derivative | |
JPH10120674A (en) | Production of 2-methyl-3-(3,4-methylenedioxyphenyl) acrylic aldehyde | |
Frankel et al. | Action of N-Chlorourethan on Derivatives of Diethyl Aminomalonate | |
US2937181A (en) | New indenothiazole | |
JPS6257618B2 (en) | ||
JPS6251273B2 (en) | ||
JP2019094317A (en) | Compound and method for producing compound | |
JPS5835518B2 (en) | (E)-5-) Beta-thikanvinyl)-2- Thienylsakusannoseizohouhou |